The adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Martine Dehlinger-Kremer, PhD
Advertisement
Articles by Martine Dehlinger-Kremer, PhD
Successful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Advertisement
Latest Updated Articles
COVID-19 Pandemic Exemplifies the Benefits of CROsMay 24th 2023
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
3
Tapping the Global Potential of China’s Biotech Surge
4
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
5